Keyphrases
Randomized Trial
100%
Antibiotic Regimen
100%
Preterm Premature Rupture of Membranes (PPROM)
100%
Roxithromycin
100%
Prophylactic Antibiotics
100%
Ampicillin
50%
Cefepime
50%
Late-onset Sepsis
33%
Klebsiella Pneumoniae (K. pneumoniae)
33%
Latency Period
33%
Escherichia Coli
16%
Antibiotics
16%
Gram-negative
16%
Length of Hospital Stay
16%
Group B Streptococcus
16%
Neonatal Outcome
16%
Respiratory Support
16%
Infectious Morbidity
16%
Ampicillin Resistance
16%
Neonatal Admission
16%
Intra-amniotic Infection
16%
Unblinding
16%
Mechanical Ventilation
16%
Neonatal Respiratory Distress Syndrome
16%
Admission to Neonatal Intensive Care Unit
16%
Clinical Trial Registry
16%
Neonatal Fever
16%
Medicine and Dentistry
Antibiotics
100%
Rupture of Membranes
100%
Roxithromycin
100%
Ampicillin
50%
Cefuroxime
50%
Sepsis
33%
Clinical Trial
16%
Artificial Respiration
16%
Streptococcus Agalactiae
16%
Neonatal Intensive Care Unit
16%
Klebsiella pneumoniae
16%
Assisted Ventilation
16%
Ampicillin Resistance
16%
Amnionitis
16%
Escherichia Coli Pneumonia
16%
Neonatal Respiratory Distress Syndrome
16%
Pharmacology, Toxicology and Pharmaceutical Science
Antibiotics
100%
Roxithromycin
100%
Ampicillin
66%
Cefuroxime
50%
Sepsis
33%
Clinical Trial
16%
Escherichia Coli Pneumonia
16%
Klebsiella pneumoniae
16%
Neonatal Respiratory Distress Syndrome
16%
Amnionitis
16%
Streptococcus Agalactiae
16%
Immunology and Microbiology
Escherichia coli
100%
Ampicillin Resistance
100%
Klebsiella pneumoniae
100%
Streptococcus Agalactiae
100%